Retirement Group, LLC Incyte Corp Transaction History

Retirement Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $10,432 - $12,838	200 New	200 $12,000
Q4 2020 Feb 22, 2021	SELL	$80.74 - $97.7 $403 - $488	-5 Closed	0 $0
Q3 2020 Sep 08, 2021	BUY	$85.07 - $109.69 $425 - $548	5 New	5 $0
Q2 2020 Sep 08, 2021	SELL	$74.18 - $108.93 $370 - $544	-5 Closed	0 $0
Q4 2019 Aug 30, 2021	BUY	$73.04 - $95.72 $365 - $478	5 New	5 $0

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Retirement Group, LLC with notifications on news.